An Open-Label, Rater-Blinded, Flexible-Dose, 8-Week Trial of Escitalopram in Patients With Major Depressive Disorder With Atypical Features

Objectives: Although selective serotonin reuptake inhibitors (SSRIs) have become the standard of care for the treatment of major depressive disorder (MDD), limited data exist to support their use in MDD with atypical features. The current study investigates the efficacy of the SSRI escitalopram in a...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Pae, Chi-Un, Masand, Prakash S., Peindl, Kathleen, Mannelli, Paolo, Han, Changsu, Marks, David M., Patkar, Ashwin A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Physicians Postgraduate Press, Inc. 2008
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2446493/
https://ncbi.nlm.nih.gov/pubmed/18615172
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky